Literature DB >> 25212567

Extended sleeve lobectomy after induction chemoradiotherapy for non-small cell lung cancer.

Shinichi Toyooka1, Junichi Soh, Hiromasa Yamamoto, Masaomi Yamane, Shigeru Hattori, Kazuhiko Shien, Kentaroh Miyoshi, Seiichiro Sugimoto, Takahiro Oto, Shinichiro Miyoshi.   

Abstract

PURPOSE: Extended sleeve lobectomy is a challenging surgery. While induction chemoradiotherapy (ChRT) followed by surgery is one of the therapeutic strategies used for locally advanced non-small cell lung cancer (NSCLC), ChRT can impair the anastomotic healing potential. We herein present our experience with cases who underwent an extended sleeve lobectomy after induction ChRT.
METHODS: The medical records of patients who underwent a surgery for NSCLC after ChRT were reviewed.
RESULTS: Between December 2007 and January 2013, nine patients underwent an extended sleeve lobectomy; the left lingular division and lower lobe in four patients, the right upper lobe and trachea in one patient, the carina and trachea in one patient, the right middle and lower lobes in one patient, the right upper and middle lobes and carina in one patient and the right upper lobe and superior segment of the lower lobe in one patient. While no postoperative 90-day deaths occurred, one case developed a bronchopleural fistula on postoperative day (POD) 25 and one case developed a bronchovascular fistula on POD 163. No cases of local recurrence developed.
CONCLUSIONS: Our experience suggests that an extended sleeve lobectomy after induction ChRT is feasible, but careful patient selection and perioperative management are mandatory.

Entities:  

Mesh:

Year:  2014        PMID: 25212567     DOI: 10.1007/s00595-014-1025-y

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  21 in total

1.  Sleeve lobectomy or pneumonectomy: optimal management strategy using decision analysis techniques.

Authors:  Mark K Ferguson; Amy G Lehman
Journal:  Ann Thorac Surg       Date:  2003-12       Impact factor: 4.330

Review 2.  Radiation effects on the lung: clinical features, pathology, and imaging findings.

Authors:  S D Davis; D F Yankelevitz; C I Henschke
Journal:  AJR Am J Roentgenol       Date:  1992-12       Impact factor: 3.959

3.  Sleeve lobectomy versus pneumonectomy for lung cancer: a comparative analysis of survival and sites or recurrences.

Authors:  Jean Deslauriers; Jocelyn Grégoire; Louis F Jacques; Michel Piraux; Liu Guojin; Yves Lacasse
Journal:  Ann Thorac Surg       Date:  2004-04       Impact factor: 4.330

4.  Sleeve lobectomy as an alternative procedure to pneumonectomy for non-small cell lung cancer.

Authors:  Joon Suk Park; Hee Chul Yang; Hong Kwan Kim; Kwhanmien Kim; Young Mog Shim; Yong Soo Choi; Jhingook Kim
Journal:  J Thorac Oncol       Date:  2010-04       Impact factor: 15.609

5.  Reconstruction of the pulmonary artery for lung cancer: long-term results.

Authors:  Federico Venuta; Anna Maria Ciccone; Marco Anile; Mohsen Ibrahim; Tiziano De Giacomo; Giorgio F Coloni; Erino A Rendina
Journal:  J Thorac Cardiovasc Surg       Date:  2009-09-09       Impact factor: 5.209

Review 6.  Severe radiation injuries of the lung.

Authors:  B Roswit; D C White
Journal:  AJR Am J Roentgenol       Date:  1977-07       Impact factor: 3.959

7.  Long-term outcome of induction chemoradiotherapy with docetaxel and cisplatin followed by surgery for non-small-cell lung cancer with mediastinal lymph node metastasis.

Authors:  Shinichi Toyooka; Katsuyuki Kiura; Mitsuhiro Takemoto; Takahiro Oto; Nagio Takigawa; Toshiyoshi Fujiwara; Shinichiro Miyoshi; Hiroshi Date
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-02-20

8.  The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.

Authors:  Peter Goldstraw; John Crowley; Kari Chansky; Dorothy J Giroux; Patti A Groome; Ramon Rami-Porta; Pieter E Postmus; Valerie Rusch; Leslie Sobin
Journal:  J Thorac Oncol       Date:  2007-08       Impact factor: 15.609

9.  A quarter of a century experience with sleeve lobectomy for non-small cell lung cancer.

Authors:  Federico Rea; Giuseppe Marulli; Marco Schiavon; Andrea Zuin; Abdel-Mohsen Hamad; Giovanna Rizzardi; Egle Perissinotto; Francesco Sartori
Journal:  Eur J Cardiothorac Surg       Date:  2008-06-25       Impact factor: 4.191

10.  Preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non-small-cell lung cancer.

Authors:  H Katayama; H Ueoka; K Kiura; M Tabata; T Kozuki; M Tanimoto; T Fujiwara; N Tanaka; H Date; M Aoe; N Shimizu; M Takemoto; Y Hiraki
Journal:  Br J Cancer       Date:  2004-03-08       Impact factor: 7.640

View more
  4 in total

1.  Extended-sleeve lobectomy: a technically demanding last-ditch effort in lung sparing surgery for central tumor.

Authors:  Charlotte Cohen; Jean-Philippe Berthet
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

2.  Extended sleeve lobectomy: its place in surgical therapy for centrally located non-small cell lung cancer and a review of technical aspects.

Authors:  Ryuichi Waseda; Akinori Iwasaki
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

3.  Extended sleeve-lobectomy for centrally located locally advanced non-small cell lung cancer is a feasible approach to avoid pneumonectomy.

Authors:  Luca Voltolini; Alessandro Gonfiotti; Domenico Viggiano; Sara Borgianni; Arianna Farronato; Stefano Bongiolatti
Journal:  J Thorac Dis       Date:  2020-08       Impact factor: 2.895

4.  Is sleeve lobectomy safe after induction therapy?-a systematic review and meta-analysis.

Authors:  Louis-Emmanuel Chriqui; Céline Forster; Alban Lovis; Hasna Bouchaab; Thorsten Krueger; Jean Yannis Perentes; Michel Gonzalez
Journal:  J Thorac Dis       Date:  2021-10       Impact factor: 3.005

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.